| NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
MATK |
DKFZp434N1212, MATK, hCG_23522: Putative uncharacterized protein DKFZp434N1212 |
0.713 |
Evidence |
|
| CD1D |
CD1D: T-cell surface glycoprotein CD1d precursor |
HLA-DRB5 |
HLA-Dw12: Cell surface glycoprotein |
0.713 |
Evidence |
|
| CD1D |
CD1D: T-cell surface glycoprotein CD1d precursor |
HLA-DMB |
HLA-DMB, DMB, RING7: HLA class II histocompatibility antigen, DM beta chain prec |
0.713 |
Evidence |
|
| HLA-DOB |
HLA-DOB: HLA class II histocompatibility antigen, DO beta chain precursor |
HLA-DRB5 |
HLA-Dw12: Cell surface glycoprotein |
0.713 |
Evidence |
|
| HLA-DOB |
HLA-DOB: HLA class II histocompatibility antigen, DO beta chain precursor |
HLA-DRB5 |
HLA-DRB3: HLA class II histocompatibility antigen, DRB3-1 beta chain precursor |
0.713 |
Evidence |
|
| HLA-DOB |
HLA-DOB: HLA class II histocompatibility antigen, DO beta chain precursor |
HLA-DMB |
HLA-DMB, DMB, RING7: HLA class II histocompatibility antigen, DM beta chain prec |
0.713 |
Evidence |
|
| GNAI3 |
GNAI3: Guanine nucleotide-binding protein G(k) subunit alpha |
GPR65 |
GPR65, TDAG8: Psychosine receptor |
0.713 |
Evidence |
|
| MMP2 |
MMP2, CLG4A: 72 kDa type IV collagenase precursor |
TNFAIP6 |
TNFAIP6, TSG6: Tumor necrosis factor-inducible protein TSG-6 precursor |
0.713 |
Evidence |
|
| SERPINA7 |
SERPINA7, TBG: Thyroxine-binding globulin precursor |
HABP2 |
HABP2, HGFAL, PHBP: Hyaluronan-binding protein 2 precursor |
0.713 |
Evidence |
|
| SERPINA5 |
SERPINA5, PCI, PLANH3, PROCI: Plasma serine protease inhibitor precursor |
ACR |
ACR, ACRS: Acrosin precursor |
0.713 |
Evidence |
O
|
| HLA-A |
HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor |
HLA-DPA1 |
HLA-DPA1, HLA-DP1A, HLASB: HLA class II histocompatibility antigen, DP alpha cha |
0.713 |
Evidence |
|
| APOE |
APOE: Apolipoprotein E precursor |
LBP |
LBP: Lipopolysaccharide-binding protein precursor |
0.713 |
Evidence |
|
| HLA-DQB1 |
HLA-DQB, HLA-DRB1: HLA class II histocompatibility antigen, DQ(1) beta chain pre |
HLA-E |
HLA-E, XXbac-BPG34K20.2-001: MHC class Ib antigen |
0.713 |
Evidence |
|
| HLA-DQB1 |
HLA-DQB, HLA-DRB1: HLA class II histocompatibility antigen, DQ(1) beta chain pre |
HLA-C |
HLA-C, HLAC: HLA class I histocompatibility antigen, Cw-7 alpha chain precursor |
0.713 |
Evidence |
|
| HLA-DQB1 |
HLA-DQB, HLA-DRB1: HLA class II histocompatibility antigen, DQ(1) beta chain pre |
HLA-A |
HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor |
0.713 |
Evidence |
|
| HLA-B |
HLA-B, HLAB: HLA class I histocompatibility antigen, B-7 alpha chain precursor |
HLA-DQB1 |
HLA-DQB, HLA-DRB1: HLA class II histocompatibility antigen, DQ(1) beta chain pre |
0.713 |
Evidence |
|
| HPR |
HPR: Haptoglobin-related protein precursor |
SERPINA10 |
SERPINA10, ZPI, UNQ707/PRO1358: Protein Z-dependent protease inhibitor precursor |
0.713 |
Evidence |
|
| IL18RAP |
IL18RAP: Interleukin-18 receptor accessory protein precursor |
IL18R1 |
IL18R1, IL1RRP: Interleukin-18 receptor 1 precursor |
0.713 |
Evidence |
|
| GRAP2 |
GRAP2, GADS, GRB2L, GRID: GRB2-related adapter protein 2 |
FYN |
IPI00640091 |
0.713 |
Evidence |
|
| SH2D1A |
SH2D1A, DSHP, SAP: SH2 domain-containing protein 1A |
MATK |
DKFZp434N1212, MATK, hCG_23522: Putative uncharacterized protein DKFZp434N1212 |
0.713 |
Evidence |
|
| SH2D1A |
SH2D1A, DSHP, SAP: SH2 domain-containing protein 1A |
FYN |
IPI00640091 |
0.713 |
Evidence |
|
| SH2D1A |
SH2D1A, DSHP, SAP: SH2 domain-containing protein 1A |
JAK1 |
|
0.713 |
Evidence |
|
| RIPK2 |
RIPK2, CARDIAK, UNQ277/PRO314/PRO34092, RICK, RIP2: Receptor-interacting serine/ |
IRAK1 |
IRAK1, IRAK: Interleukin-1 receptor-associated kinase 1 |
0.713 |
Evidence |
|
| CFLAR |
CFLAR, CASH, CASP8AP1, CLARP, MRIT: CASP8 and FADD-like apoptosis regulator prec |
IRAK4 |
IRAK4: Interleukin-1 receptor-associated kinase 4 |
0.713 |
Evidence |
|
| LSM1 |
LSM1, CASM: U6 snRNA-associated Sm-like protein LSm1 |
SNRPB |
SNRPB, COD, SNRPB1: Small nuclear ribonucleoprotein-associated proteins B and B' |
0.713 |
Evidence |
|